DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Anti-influenza M2e antibody

Abstract

Humanized recombinant and monoclonal antibodies specific for the ectodomain of the influenza virus M2 ion channel protein are disclosed. The antibodies of the invention have anti-viral activity and may be useful as anti-viral therapeutics and/or prophylactic/vaccine agents for inhibiting influenza virus replication and for treating individuals infected with influenza.

Inventors:
 [1]
  1. Santa Fe, NM
Issue Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1034171
Patent Number(s):
8080244
Application Number:
12/592,241
Assignee:
Los Alamos National Security, LLC (Los Alamos, NM)
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
DOE Contract Number:  
AC52-06NA25396
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Bradbury, Andrew M. Anti-influenza M2e antibody. United States: N. p., 2011. Web.
Bradbury, Andrew M. Anti-influenza M2e antibody. United States.
Bradbury, Andrew M. Tue . "Anti-influenza M2e antibody". United States. https://www.osti.gov/servlets/purl/1034171.
@article{osti_1034171,
title = {Anti-influenza M2e antibody},
author = {Bradbury, Andrew M},
abstractNote = {Humanized recombinant and monoclonal antibodies specific for the ectodomain of the influenza virus M2 ion channel protein are disclosed. The antibodies of the invention have anti-viral activity and may be useful as anti-viral therapeutics and/or prophylactic/vaccine agents for inhibiting influenza virus replication and for treating individuals infected with influenza.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2011},
month = {12}
}

Works referenced in this record:

Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models
journal, January 2007


Effects of humanization by variable domain resurfacing on the antiviral activity of a single-chain antibody against respiratory syncytial virus
journal, April 1999